These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6188892)

  • 41. The treatment of ventricular rhythm disturbances.
    Somberg JC; Miura D; Keefe DL
    Am Heart J; 1986 Jun; 111(6):1162-76. PubMed ID: 2424297
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effects of anti-arrhythmia agents on heart rate. Significance and importance].
    Leclercq JF; Georgiopoulos G; Halkidis H; Attuel P; Maisonblanche P; Coumel P
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():37-46. PubMed ID: 6122434
    [No Abstract]   [Full Text] [Related]  

  • 43. Antiarrhythmic and circulatory effects of Astra W36095, a new lidocaine-like agent.
    Coltart DJ; Berndt TB; Kernoff R; Harrison DC
    Am J Cardiol; 1974 Jul; 34(1):35-41. PubMed ID: 4835751
    [No Abstract]   [Full Text] [Related]  

  • 44. Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats.
    Mertz TE; Kaplan HR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):580-6. PubMed ID: 7131307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mexiletine (Kö 1173) in the management of ventricular dysrhythmias.
    Campbell NP; Kelly JG; Shanks RG; Chaturvedi NC; Strong JE; Pantridge JF
    Lancet; 1973 Aug; 2(7826):404-7. PubMed ID: 4124890
    [No Abstract]   [Full Text] [Related]  

  • 46. Lidocaine as an antiarrhythmic Experience in 68 patients.
    Flensted-Jensen E; Sandoe E
    Acta Med Scand; 1969 Apr; 185(4):297-302. PubMed ID: 4185142
    [No Abstract]   [Full Text] [Related]  

  • 47. Intravenous lorcainide versus lidocaine in the treatment of frequent and complex ventricular arrhythmias.
    Blevins RD; Kerin NZ; Mathias P; Pesola D; Faitel K; Jarandilla R; Garfinkel C; Rubenfire M
    Am Heart J; 1986 Mar; 111(3):447-51. PubMed ID: 3953351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Double-blind randomized comparison of intravenous tocainide versus lidocaine in the treatment of chronic ventricular arrhythmias.
    Mohiuddin SM; Hilleman DE; Mooss AN; Esterbrooks D; Sketch MH; Stengel LA; Butler ML
    Am Heart J; 1987 Aug; 114(2):296-302. PubMed ID: 3111238
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flecainide: a new antiarrhythmic drug.
    Med Lett Drugs Ther; 1986 Feb; 28(707):19-20. PubMed ID: 3951388
    [No Abstract]   [Full Text] [Related]  

  • 50. Efficacy of oral pirmenol in suppressing ventricular premature depolarisations.
    de Buitleir M; Crevey B; Johnson T; Baerman J; Morady F
    Ir Med J; 1987 Feb; 80(2):60-3. PubMed ID: 2435676
    [No Abstract]   [Full Text] [Related]  

  • 51. Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
    Podrid PJ
    Chest; 1985 Oct; 88(4):618-24. PubMed ID: 3930162
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of intravenous flecainide on atrial vulnerability in man.
    Pop T; Treese N
    Drugs; 1985; 29 Suppl 4():1-6. PubMed ID: 4006774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and pharmacokinetics of oral pirmenol, a new antiarrhythmic drug.
    Garg DC; Jallad NS; Singh S; Ng KF; Weidler DJ
    J Clin Pharmacol; 1988 Sep; 28(9):812-7. PubMed ID: 2466056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tocainide: a new oral antiarrhythmic agent.
    Kutalek SP; Morganroth J; Horowitz LN
    Ann Intern Med; 1985 Sep; 103(3):387-91. PubMed ID: 3927807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia.
    Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN
    Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes.
    Kjekshus J; Bathen J; Orning OM; Storstein L
    Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of tocainide, encainide, lorcainide and flecainide for supraventricular arrhythmias.
    Orning OM
    Eur Heart J; 1984 Sep; 5 Suppl B():81-6. PubMed ID: 6437821
    [No Abstract]   [Full Text] [Related]  

  • 58. Lidocaine (Xylocaine) as an anti-arrhythmic agent.
    Med Lett Drugs Ther; 1971 Jan; 13(1):1-2. PubMed ID: 4104507
    [No Abstract]   [Full Text] [Related]  

  • 59. The clinical pharmacology of lidocaine as an antiarrhythymic drug.
    Collinsworth KA; Kalman SM; Harrison DC
    Circulation; 1974 Dec; 50(6):1217-30. PubMed ID: 4609637
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of lorcainide, a new anti-arrhythmic agent.
    Lloyd EA; Workman LJ; Commerford PJ; Mabin TA
    S Afr Med J; 1981 Dec; 60(24):929-31. PubMed ID: 7302777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.